Endoscopy & Visualization

Centerline Biomedical develops intraoperative navigation technology for endovascular and interventional procedures. The company's flagship product, IOPS® (Intra-Operative Positioning System), is a 510(k)-cleared navigation platform that provides real-time 3D color image guidance as an alternative to conventional X-ray fluoroscopy. IOPS® is designed to mitigate occupational and patient radiation exposure in interventional cardiology, vascular surgery, and complex endovascular procedures. The system offers interactive navigation, high-quality 3D imaging, and portability compared to traditional 2D fluoroscopy-based guidance. Clinical evidence presented on the site documents significant occupational hazards associated with fluoroscopy exposure, including radiation-induced cataracts, brain tumors, and orthopedic issues among interventionalists. IOPS® targets procedures estimated at 4 million annually in the United States. The company collaborates with major medical institutions including Cleveland Clinic, the U.S. Air Force 59th Medical Wing, and the U.S. Army Institute of Surgical Research, indicating validation in both civilian and military surgical settings. The technology is positioned for vascular surgeons, interventional cardiologists, and trauma surgeons performing endovascular therapy, aortic procedures, and complex case management where radiation dose is a clinical and occupational concern.

Stevanato Group is a global leader in integrated solutions for the pharmaceutical and biotechnology industries, with over 75 years of expertise in drug containment, drug delivery systems, and in-vitro diagnostic solutions. The company manufactures glass primary packaging (vials, cartridges, syringes) for pharmaceutical products, pre-filled syringe systems including the Alba® platform for biologics, and specialized injection needles such as the sTW (Special Thin Wall) needle for high-viscosity drugs. The Aidaptus® autoinjector platform provides flexible drug delivery mechanisms. Stevanato operates advanced manufacturing facilities in Fishers, Indiana (US hub for North American customers), Monterrey (Mexico), and Zhangjiagang (China). The company provides visual inspection systems, secondary packaging solutions, assembly equipment, glass-converting automation, and analytical testing services for container-closure systems and drug interactions. Products serve development, clinical, and commercial stages of the drug lifecycle. The group maintains ISO certifications and regulatory compliance across major markets and offers contract manufacturing competencies integrated with proprietary technologies. Recent innovations include Digital Holographic Microscopy (DHM®) for silicone coating characterization and advanced syringe formulations for IV drug delivery compatibility.

Radiaction Medical develops scatter radiation protection systems for interventional cardiology, electrophysiology, and fluoroscopy-guided procedures. The company's primary product, the Radiaction Smart Shield, is a dynamic barrier system that deploys at the C-arm fluoroscopy system rather than requiring personnel to wear lead aprons, reducing occupational radiation exposure by over 90% according to clinical testimonials. The system deploys and retracts in 2–3 seconds, maintaining workflow efficiency in high-volume interventional labs. Radiaction's technology is designed for use in cardiac catheterization laboratories, electrophysiology labs, and operating rooms where C-arm guidance is employed. The company has clinical validation from major academic medical centers including Assuta Ashdod University Medical Center, with endorsements from interventional cardiologists and electrophysiologists. The Smart Shield addresses a documented occupational health concern: cumulative scatter radiation exposure linked to increased risk of brain tumors, breast cancer, cataracts, cognitive degradation, thyroid disease, and orthopedic injury among interventional staff. Radiaction has established a medical advisory board and has been featured in peer-reviewed and clinical trade publications including Cardiac Interventions Today and TCT (Transcatheter Cardiovascular Therapeutics). The company targets hospital systems seeking to improve occupational safety compliance while maintaining procedural volume and staff retention in high-radiation environments.

Canon Medical Informatics develops enterprise imaging software and advanced visualization platforms for healthcare systems. Their flagship product, Vitrea® Advanced Visualization, is a cloud-ready platform designed to consolidate imaging environments, automate workflows, and enable in-house 3D imaging capabilities across cardiology, thoracic, and general radiology applications. The platform includes specialized modules such as CT VScore+ for automated cardiac calcium scoring, Open Rib for chest CT image reformation and PACS integration, and Export+ for structured data delivery and clinical documentation. Vitrea supports PACS integration, provides enterprise scalability, and delivers AI-assisted diagnostic insights to streamline radiologist workflows and reduce manual data entry. The company serves health systems, imaging centers, and enterprise hospital networks seeking to consolidate point solutions, enable advanced visualization services in-house, and improve operational efficiency. Canon Medical Informatics is part of Canon's broader healthcare IT portfolio and focuses on clinical software, imaging AI, and decision-support solutions for the radiology enterprise.

Instrumed Surgical is a privately held Canadian medical device distributor and manufacturer established in 1987, holding Health Canada's Medical Device Establishment Licence (MDEL). The company specializes in endoscopy and surgical segments, supplying hospitals and healthcare facilities across Canada and the United States. Instrumed Surgical offers surgery supplies, stents, and medical devices with nationwide representation covering major Canadian cities. Beyond distribution, the company provides regulatory expertise, assisting international manufacturers with MDSAP approval, CE certification, and ISO 13485 compliance to facilitate market entry into Canada, the US, Australia, Brazil, and Japan. The company maintains quality assurance and regulatory compliance as core pillars, with experienced sales professionals engaging major hospitals and participating in medical conferences and trade shows.

Integrity Medical Products is a B2B supplier of medical equipment accessories, replacements, and consumables for healthcare facilities. The company specializes in patient monitoring cables and sensors (SpO2, ECG, invasive/non-invasive blood pressure) compatible with major monitor brands, available at 30–60% savings versus OEM pricing, with one-year warranties. Product portfolio includes monitor mounting arms and cable management systems (five-year warranty), nurse call accessories with pillow speakers (two-year warranty), medical carts and stands for monitors, ventilators, and suction pumps, and hospital furniture including overbed tables, bedside cabinets, fetal monitoring carts, bassinets, stools, and chairs with antimicrobial construction. Integrity also supplies suction and oxygen therapy products (analog and digital suction regulators, portable suction pumps, flowmeters, gas regulators, cylinder carts, high-pressure hoses) and offers patent-pending Integrated Flowmeter technology. Additional product lines include diagnostic systems (ophthalmoscopes/otoscopes with Welch Allyn compatibility), endoscopy/OR monitors and video accessories (wireless transmitters, fiber optic light cords, custom screen protectors), operating room table and stretcher pads (gel, foam, and self-adjusting air options for pressure ulcer prevention), and bed and stretcher accessories with custom fabrication available. The company targets hospitals, surgical centers, and critical care facilities, emphasizing affordability, compatibility with existing infrastructure, and practical solutions to institutional procurement challenges.

Burton Medical is an ISO 13485-certified, FDA-registered medical device manufacturer specializing in high-performance LED lighting solutions for surgical, examination, and procedural applications in human and veterinary healthcare. Established in 1928 and headquartered in Addison, Illinois, the company has deployed over 400,000 lights globally over its 95+ year history. Burton Medical manufactures a comprehensive portfolio of LED lighting products including surgical lights (APEX LED, AIM HI LED), examination lights (Nova Exam LED, Super Exam LED, Outpatient LED), and magnification lights (UV LED Magnifier, Epic LED Magnifier) that deliver glare-free illumination and precise color rendering for demanding clinical environments. All products meet UL/IEC 60601-1 and CE standards. The company's U.S.-based manufacturing enables rapid lead times and supply chain resilience. Burton Medical products carry a five-year warranty.

Michelson Diagnostics Ltd is the world leader in practical Optical Coherence Tomography (OCT) dermatology applications. Founded in 2006 by five physicists and engineers, the company develops and manufactures VivoSight Dx Pro, a state-of-the-art OCT skin imaging system used in clinical dermatology, commercial research, and academic skin research. VivoSight employs eye-safe infrared scanning laser light to provide non-invasive, high-resolution (sub-10 μm) 3D morphologic and angiographic imaging of skin microstructure up to 1 mm depth with a 6 mm × 6 mm field-of-view. The system enables objective measurement of skin parameters for diagnosis and monitoring of conditions including basal cell carcinoma, eczema, atopic dermatitis, and vascular lesions (port wine stain). The VivoSight product line has been cited in over 800 peer-reviewed publications. The company holds EU MDR certification and operates globally from offices in the UK, USA, and Germany, serving dermatology practices, hospitals, and research institutions.

CooperSurgical is a global leader in women's health and fertility solutions, headquartered in Trumbull, Connecticut. As a key business unit of The Cooper Companies, Inc., the company develops and distributes innovative medical devices, surgical instruments, and diagnostic tools for reproductive care, obstetrics, gynecology, and general women's health. Founded in 1990, CooperSurgical operates a 214,000-square-foot manufacturing and distribution facility in Connecticut and maintains a presence across North America, Europe, Asia-Pacific, and the Middle East. The company offers over 600 products served through multiple trusted brands, addressing healthcare needs from contraception and fertility through labor and delivery. With manufacturing expertise in molecular diagnostics, embryology systems, advanced hysteroscopy, and minimally invasive surgical technologies, CooperSurgical serves healthcare providers through direct sales, distribution networks, and comprehensive support services including preventative maintenance, product training, and spare parts availability. The company employs over 3,000 people and generates annual revenue exceeding $680 million.

Stellartech Research Corporation is an ISO 13485:2016-registered contract manufacturer and product development partner specializing in sophisticated medical devices utilizing radiofrequency, ultrasound, and other energy-delivery sources. The company designs and manufactures complex medical systems that typically combine disposable patient-contact devices with microprocessor-controlled instruments featuring advanced electronics for sensor feedback and controlled therapeutic energy delivery. Core competencies include catheter-based systems (including balloon electrode catheters), surgical probes, diagnostic instruments, and minimally invasive therapy devices. Stellartech operates a 68,000 sq. ft. facility capable of manufacturing Class II and Class III devices under FDA QSR compliance and ISO 13485:2016 quality management systems. Beyond contract manufacturing, the company provides full-spectrum product development services—from concept and proof-of-principle through clinical evaluation, regulatory approval, and market introduction. Stellartech partners with device companies of all sizes, medical entrepreneurs, physicians, and investment groups, offering incubation services for new medical device enterprises using its manufacturing infrastructure and regulatory expertise. The company brings integrated capabilities in RF and ultrasound energy systems, complex electronics design, catheter technology, and regulatory pathway management, positioning it as a strategic partner for medical device innovators seeking to navigate the product development lifecycle.

Revvity, Inc. is a comprehensive life science solutions provider serving academia, pharmaceutical, biotech, clinical laboratories, contract research organizations, and healthcare professionals globally. The company operates across the drug discovery-to-diagnostics continuum, delivering integrated workflows in translational multi-omics, biomarker identification, imaging, screening, detection, diagnosis, and informatics. Product portfolio includes high-content screening instruments (Opera Phenix, EnVision plate readers), optical imaging systems (IVIS), cell analysis instruments (Cellometer), sample preparation equipment (Omni Bead Ruptor Elite homogenizers), and laboratory automation (Fontus workstations, LabChip systems). Reagent brands encompass BioLegend antibodies and flow cytometry reagents, AlphaLISA and SureFire immunoassays, HTRF TR-FRET assays, Dharmacon RNAi and CRISPR tools, and custom oligonucleotide synthesis. Representative diagnostic and clinical service offerings include newborn screening (33M+ annual screens), immunodiagnostics via EUROIMMUN solutions (85M+ blood samples analyzed), infectious disease serology, TB testing (T-SPOT.TB, 20M+ tested since 2002), reproductive health solutions (maternal/prenatal testing, cell-free DNA analysis, preeclampsia management), and clinical genomics services (300M+ tests performed). Licensing portfolio covers gene expression, editing, and viral vector technologies including LentiBOOST and Pin-point base editing platforms. Revvity serves 94% of top 50 global pharma companies, maintains ~11,000 employees worldwide, and operates on-site manufacturing, viral vector engineering, preclinical oncology services, and clinical testing. Regulatory presence includes FDA and CE approvals across diagnostics and instruments. The company integrates acquisition-driven growth with organic R&D, supporting discovery through clinical deployment across life science workflows.

Rapid AI develops deep clinical artificial intelligence software for medical imaging analysis, specializing in neurovascular, cardiac & vascular, and radiology applications. The company's Rapid Enterprise™ Platform delivers FDA-cleared clinical decision support modules that enhance diagnostic confidence and streamline workflows across 2,500+ hospitals in 100+ countries. Core offerings include AI-driven triage, localization, quantification, characterization, and 3D visualization capabilities for stroke (hemorrhagic and ischemic), aneurysm, pulmonary embolism, and general radiology cases. The mobile app enables real-time alerts, case collaboration, DICOM viewer integration, EMR connectivity, and procedural workflow initiation. Rapid AI products include Lumina 3D (advanced 3D rendering and analysis, named to TIME's Best Inventions 2025), Navigator Pro (radiology workflow prioritization), and Rapid Insights (custom analytics). The company has received 30 FDA-cleared modules and maintains extensive clinical validation: 700+ peer-reviewed publications, 25+ clinical trials, 11 NEJM publications, and 17.5 mean impact factor. Processing 20,000+ daily scans, Rapid AI serves stroke centers, trauma departments, cardiac services, and life sciences organizations conducting clinical trials. The platform supports interoperability with third-party healthcare systems and EMRs, enabling cross-disciplinary deployment of AI decision support.

Rudolf Riester GmbH (Riester USA) is a German manufacturer of medical diagnostic devices established in 1948 and based in Jungingen, Baden-Württemberg. Part of Halma plc since 2007, Riester operates globally across over 150 countries with approximately 99 employees and $30.1 million in annual revenue. The company specializes in precision diagnostic and monitoring devices for primary care and specialist settings, including stethoscopes, blood pressure monitors, pulse oximeters, otoscopes, ophthalmoscopes, and digital medical camera systems. Riester also offers telemedicine solutions through strategic partnerships such as Docs in Clouds TeleCare GmbH, enabling remote healthcare delivery. The product portfolio emphasizes clinical accuracy, reliability, and innovation to support healthcare providers in improving patient outcomes across diverse clinical environments.

Optosurgical is an early-stage medical device company developing intraoperative imaging technologies to enhance surgical safety and precision. The company specializes in fluorescence-guided surgery systems that deliver real-time structural and functional tissue visualization to surgeons. Their flagship product, hANDY-i, is a hand-held imaging device designed to prevent parathyroid gland damage during thyroid removal surgery without requiring contrast agents. The company also develops 3DMAV (3D Multi-Angle-View) technology for single-lens systems and advanced visualization solutions for biliary and other complex abdominal surgeries. Optosurgical's mission is to make critical anatomy visible intraoperatively, reducing operative time and improving surgical outcomes across thyroid, bile duct, and other complex procedural domains.

Grifols is a leading global biopharmaceutical and healthcare company founded in 1909, headquartered in Barcelona with significant US operations. The company operates across four primary business divisions: Biopharma (plasma-derived medicines and biopharmaceuticals for immunology, hepatology, intensive care, pulmonology, hematology, neurology, and infectious diseases), Diagnostic (blood screening and transfusion medicine diagnostics), Bio Supplies (plasma collection and processing supplies), and Healthcare Solutions for Hospitals (hospital equipment and consumables). Grifols manufactures and distributes innovative plasma-derived therapeutic products, clinical laboratory equipment and reagents, diagnostic assays, and healthcare infrastructure solutions for hospital and transfusion medicine settings. The company operates a global plasma donation center network and engages in research and development across multiple therapeutic areas, including immunological disorders, rare diseases, and infectious disease screening. Grifols maintains regulatory compliance with FDA approvals (evidenced by recent malaria blood screening assay approval), ISO standards, and international quality certifications. The company serves healthcare systems, blood banks, hospitals, clinical laboratories, and patients globally, with established operations and partnerships across the Americas, Europe, and Asia-Pacific regions.

Palliare is a medtech company specializing in insufflation systems for minimally invasive surgical and endoscopic procedures. The company designs and manufactures the EVA15 Insufflator, a modernized insufflation device that delivers hands-free control and constant pressure maintenance in the surgical working field. The EVA15 is indicated for use in laparoscopic surgery, colorectal procedures, endolumenal interventions, and robotic-assisted surgery. The system provides automated insufflation management, reducing manual intervention during procedures and improving operational efficiency in the OR and endoscopy suite. Palliare positions itself as a technology leader focused on advancing insufflation capabilities to support the growing adoption of minimally invasive techniques across surgical specialties. The company has received recognition in the medtech industry, winning the Emerging Medtech Company of the Year award at the 2025 Irish Medtech Awards, indicating strong market validation and innovation credentials.

Technomed Medical Parts & Equipment (TEMPE) is a global supplier of advanced medical imaging equipment, parts, and services with over 36 years of operational history. The company operates as a multi-location distributor and service provider across North America and Europe, offering new and pre-owned medical imaging systems from leading manufacturers including DEL Medical, Mindray, Sonostar, Mevis, and NewTom. Product lines encompass MRI systems, CT scanners, X-ray systems (including C-arm), ultrasound equipment, mammography systems, nuclear medicine imaging, and dental imaging (OPG) systems. Technomed maintains a substantial inventory of OEM parts for all major modalities—MRI, CT, ultrasound, mammography, nuclear medicine, X-ray, and C-arm—supporting both new installations and ongoing maintenance. The company provides comprehensive service capabilities including equipment installation and deinstallation, CT tube replacement, operator and technical training, technical procedures, and remote maintenance and support. Technomed serves human medical clinics, independent imaging centers, and veterinary practices across Canada, the USA, and Europe. The organization holds relevant certifications for medical device distribution and maintains compliance with medical imaging standards. With offices in Ontario (Mississauga), British Columbia (Richmond), Washington state (Kirkland), and Germany (Laer), Technomed functions as both a new equipment distributor and an established player in the refurbished and parts market.

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. Founded in 1987 and headquartered in South Jordan, Utah, the company employs approximately 7,000 people worldwide and serves hospitals and physicians across the globe. Merit specializes in devices for cardiology, radiology, oncology, critical care, and endoscopy applications. The product portfolio includes catheters, guide wires, balloons, inflation devices, syringes, needles, stents, biopsy tools, drainage systems, embolics and delivery systems, access devices, and monitoring equipment. Merit serves multiple clinical specialties including interventional cardiology, interventional radiology, gastroenterology, critical care, electrophysiology, nephrology, pulmonology, breast surgery, and interventional oncology. The company offers procedural solutions for cardiac catheterization, dialysis access, biopsy procedures, embolotherapy, stricture management, spine interventions, and structural heart applications. Merit operates globally with manufacturing and distribution capabilities supporting complex interventional procedures. The company provides clinician education through Merit's Think Education program and maintains regulatory compliance appropriate for disposable medical devices in the United States and international markets.

Digital Diagnostics Inc. is a clinical software company specializing in FDA-cleared artificial intelligence platforms for autonomous medical diagnosis. The company's flagship product, LumineticsCore®, is an FDA-cleared AI diagnostic system that identifies diabetic retinopathy at the point-of-care using fundus imaging analysis, capable of providing diagnosis within 30 seconds without requiring physician interpretation. LumineticsCore integrates with electronic health record systems (EPIC) and is reimbursable via CPT code 92229, enabling primary care and community health settings to perform diabetic eye examinations and close HEDIS quality care gaps. The company serves healthcare systems, primary care clinics, community health centers, and urgent care facilities nationwide, with documented real-world evidence demonstrating increased screening adherence, improved referral follow-up rates, and enhanced provider efficiency. Digital Diagnostics is actively researching additional ophthalmologic and systemic disease applications including glaucoma, age-related macular degeneration, cardiovascular indications, and neurodegenerative conditions detectable via retinal imaging. The company emphasizes health equity, regulatory compliance, and evidence-based outcomes through peer-reviewed publications and case studies from institutions including Stanford Health System, Johns Creek Primary Care, Tarzana Treatment Centers, and Cahaba Medical Care.

MolecuLight Inc. manufactures advanced wound care diagnostic imaging devices that detect harmful bacteria in wounds using real-time, non-invasive fluorescence imaging technology. The company's flagship product line includes the MolecuLight i:X and MolecuLight DX platforms, which provide multimodal imaging capabilities for wound assessment. The DX model features integrated thermal imaging for non-contact skin temperature visualization with ±0.5°C accuracy, automated digital wound measurement with auto-depth capability, and comprehensive wound documentation. Both devices are Class II FDA-cleared and CE-marked, validated for bacterial detection and infection identification across all skin tones. The imaging platform is EHR-integrated with all leading electronic health record systems and features HIPAA and SOC II Type 2 compliance for secure data management. Clinical evidence demonstrates 79% greater wound area reduction by 12 weeks when harmful bacteria detected by MolecuLight are removed, and 2x more wounds healed by 12 weeks when using MolecuLight to inform wound care versus standard of care. The technology is contrast-free and requires no patient contact or stickers for measurement. Products are designed for point-of-care use in wound care settings, supporting individualized treatment protocols and evidence-based outcome tracking.

EyeCheq develops and deploys automated diabetic retinopathy screening kiosks that perform non-mydriatic retinal imaging and vision assessment in healthcare settings. The EyeCheq screening device conducts four integrated assessments: eye health survey, visual acuity testing, objective eye measurements (refraction), and digital retinal imaging analyzed by licensed ophthalmologists. Retinal images are reviewed to detect signs of diabetic retinopathy, hypertension, and other systemic health conditions affecting vision. The platform targets health plans and healthcare providers seeking to close diabetic retinal exam care gaps required for HEDIS and STAR quality measures. Designed for minimal staff requirements and easy deployment in retail pharmacies, primary care clinics, and portable settings, the kiosk operates on a subscription model with dedicated CPT reimbursement codes. The company offers a web-based partner portal for patient management and screening workflow integration. Market focus includes preventive eye care, population health management, and vision equity initiatives, particularly for diabetic patients at risk of sight-threatening complications.

Vitazi.ai is a software and AI analytics company specializing in oculomics—the extraction of systemic health biomarkers from retinal imaging. The platform transforms routine retinal scans into multi-disease screening tools, detecting early signs of diabetic retinopathy, glaucoma, age-related macular degeneration (AMD), hypertensive retinopathy, cardiovascular disease risk factors, and neurological disorder indicators. The solution operates as a cloud-based service accessible via secure API with EHR integration, designed for optometrists, primary care practices, health systems, and telehealth networks. Vitazi offers a tiered product approach: AI-only screening for single conditions (diabetic retinopathy, glaucoma, AMD); telehealth-enabled staging with specialist oversight; and proprietary oculomics technology combining quantitative retinal analysis with systemic risk assessment (not yet FDA cleared). The company targets the growing preventive care market, leveraging the fact that over 60% of U.S. optometry practices already possess retinal imaging equipment, eliminating infrastructure barriers. Clinical backing is rooted in 21,000+ peer-reviewed publications on oculomics since 2020. Key value propositions include new reimbursable CPT codes (92250) for optometrists, improved HEDIS/STAR/MIPS quality metrics for health systems, and earlier disease detection for chronic conditions. The platform includes built-in specialist referral networks and guidance on clinical next steps. Vitazi positions itself at the intersection of rising chronic disease prevalence, provider shortage projections (35,000 PCPs and 81,000 specialists by 2035), and the emerging digital biomarkers market (projected $14B by 2030).

Praxis Medical LLC is a medical device company headquartered in Tampa, Florida, specializing in motorized, rotating fine needle biopsy systems. The company develops innovative, minimally invasive biopsy devices designed to improve diagnostic outcomes in soft tissue and pulmonary sampling. Their primary product lines include CytoCore, a percutaneous soft tissue biopsy system for radiology applications, and EndoCore, an endobronchial ultrasound (EBUS)-guided biopsy device for pulmonology. Both systems utilize proprietary rotary needle technology that enables collection of core-comparable tissue samples in fewer needle passes compared to standard fine needle aspiration (FNA) techniques. The devices employ non-firing needle mechanisms to prioritize patient safety while maintaining high specimen quality for diagnosis and disease staging. Praxis Medical targets interventional radiologists, pulmonologists, and diagnostic specialists in hospital and outpatient surgical settings. The company emphasizes minimally invasive approaches, reduced procedural passes, improved diagnostic yield, and enhanced patient outcomes as key differentiators. Manufacturing and regulatory status information is not detailed on the website; clinical validation and regulatory pathway details are not explicitly stated.

Fovia, Inc. is a leading provider of cloud-based, vendor-neutral AI visualization and advanced medical imaging software solutions. The company develops F.A.S.T.® aiCockpit® and F.A.S.T.® AI SDK—flagship products that enable radiologists and clinicians to efficiently access and interact with AI results directly within their existing PACS, reporting software, and hospital systems without launching external viewers. Fovia's comprehensive product suite includes F.A.S.T.® AI Annotation, F.A.S.T.® AI Validation, F.A.S.T.® AI Workflows, F.A.S.T.® Interactive AI, and F.A.S.T.® Interactive Segmentation, providing OEMs and enterprises with tools for annotation, validation, modification, segmentation, and AI result management in 2D and 3D. The platform consolidates multi-vendor AI algorithm results into a single unified interface, streamlining radiology workflows and reducing integration complexity. With over 20 years of radiology integration experience, Fovia offers flexible deployment options (floating web application, embedded browser, widget mode, or SDK implementation) and supports seamless integration across diverse platforms and operating systems for both clinical and research applications.

IZI Medical Products LLC is a medical device manufacturer and distributor specializing in minimally invasive diagnostic and therapeutic solutions for interventional radiology, spine surgery, and related clinical specialties. The company manufactures and distributes products across several core clinical areas: vertebral compression fracture (VCF) treatment systems including the Kiva VCF Treatment System, Blazer-C Vertebral Augmentation System, and Osteo-Site Vertebral Balloon; bone cement products such as Vertefix MV (infused with Insite Tracking Beads for enhanced visualization during vertebroplasty and kyphoplasty); soft tissue biopsy and breast localization products including the Quick-Core Auto programmable automatic biopsy system; and spine augmentation and fixation devices. The company serves hospitals, interventional radiology departments, spine surgery centers, and diagnostic imaging facilities. Products are designed for vertebral augmentation, vertebroplasty, kyphoplasty, soft tissue biopsy, and image-guided surgical procedures. IZI Medical operates as both a manufacturer and distributor, with capabilities spanning product development, regulatory compliance, and clinical market support. The company focuses on clinically appropriate, integrated treatment solutions that combine diagnostic and therapeutic capabilities for minimally invasive spine and interventional procedures.

BC Group International, Inc. (operating as Lloyd Industries, Inc.) is a comprehensive distributor and manufacturer of biomedical test equipment and measurement instruments for the global medical device technical services marketplace. The company functions as a "one-stop-shop" providing sales of test equipment and tools, calibration services, and repair services for general and biomedical-specific test equipment across multiple brands and types. BC Group manufactures and distributes its proprietary BC Biomedical line of products, which includes Electrical Safety Analyzers, Defibrillator Analyzers, Electrosurgical (ESU) Analyzers, Infusion Device Analyzers, NIBP Simulators, Patient Simulators, Pulse Oximetry (SpO2) Simulators, and Digital Pressure Meters (standard and high-accuracy variants). The product portfolio encompasses testing and measurement equipment for anesthesia and respiratory systems, medical gas analysis, oxygen analyzers, HVAC systems, environmental air quality monitoring, cable and LAN testers, EMF monitors, power line disturbance monitors, ultrasound imaging and wattmeters, radiology equipment, temperature and humidity monitoring, and general-purpose test equipment including multimeters, oscilloscopes, and tachometers. The company operates multiple service divisions: BC Depot (depot calibration and repair), BC Onsite (on-site calibration services), and BC Quality Programs (certified quality assurance). BC Group maintains an online store and offers downloadable product catalogs, manuals, and technical references. The company serves biomedical engineering departments, clinical engineering teams, hospitals, medical device manufacturers, and service organizations. All products are available through their online marketplace, and the company emphasizes compliance with industry standards and regulations for biomedical equipment testing and validation.

Intuitive Surgical, Inc. is a global leader in robotic-assisted surgical systems and digital health solutions. The company manufactures the da Vinci family of robotic surgery platforms, which enable minimally invasive surgical procedures across multiple specialties including general surgery, urology, gynecology, cardiothoracic, and orthopedics. Core product lines include the da Vinci 5 (advanced integrated robotic platform with surgeon console and patient cart), the da Vinci SP (single-port robotic system for new surgical approaches), and the Ion robotic bronchoscopy system for lung cancer diagnosis and biopsy. Intuitive also manufactures da Vinci instruments and accessories designed for precision and ergonomic control. Beyond hardware, the company provides digital solutions including My Intuitive (data analytics and insights platform for surgical teams) and SimNow (surgeon training and simulation software). The company operates a global infrastructure with expanded direct operations in Europe and provides 24/7 service and support. Intuitive's systems are used in hospitals worldwide for minimally invasive surgery, and the company has established itself as the market leader in robotic-assisted surgical technology since its founding in 1995. The platform emphasizes surgeon autonomy, precision, and patient outcomes through advanced visualization and control systems.

Diagnomatic is a healthcare technology company specializing in automated quality assurance (QA) solutions for medical imaging equipment. Operating as a division of Pro-Project (Poland), Diagnomatic combines intelligent software platforms, benchmarking test phantoms, and cloud-based processing to enhance diagnostic accuracy and ensure regulatory compliance across multiple imaging modalities. The company's integrated QA platform supports CT, MRI, mammography, radiography, fluoroscopy, ultrasound, nuclear medicine, and radiotherapy equipment. Core offerings include automated image scoring with instant failure alerts, enterprise-grade software with audit-ready reporting, ACR-approved test phantoms, and flexible cloud or on-premise deployment options. Diagnomatic holds ISO 9001, 13485, 14001, 27001, and 45001 certifications, with endorsements from major OEMs (GE, Siemens, Philips, Toshiba, Canon, FujiFilm) and leading hospital networks. The platform significantly reduces QA testing time, minimizes downtime, facilitates team collaboration, and accelerates accreditation readiness.

Intelligent Retinal Imaging Systems (IRIS) develops cloud-based retinal screening software designed to identify and manage diabetic retinopathy and other retinal pathologies. The company provides a comprehensive solution combining digital retinal imaging capture, image enhancement, remote interpretation by board-certified ophthalmologists, and integration with existing electronic medical records (EMR) systems. IRIS operates a camera-agnostic platform compatible with multiple imaging devices, enabling healthcare providers to conduct preventive retinal screenings in primary care settings, federally qualified health centers (FQHCs), hospitals, health plans, pharmacies, and health risk assessment companies. The platform securely stores and manages patient information, with results delivered to providers within target timeframes. Implementation includes customized workflow integration, staff training, hardware recommendations, and ongoing technical support. The solution is designed for rapid deployment, with typical go-live in 90 days. IRIS serves diverse healthcare organizations including major health systems (Prisma Health, St. Elizabeth Physicians, LifeBridge), health insurance plans, and community care networks. The company emphasizes care gap closure for diabetic patients, reducing preventable blindness, and improving quality compliance measures. As of 2025, Intelligent Retinal Imaging Systems was acquired by Topcon Healthcare to enhance connected care across primary and eye care settings.

Jiangsu Yongle Medical Technology Co., Ltd. is a professional manufacturer of anesthetic laryngoscopes and endoscopic visualization equipment with 19 years of production experience. Founded in 2014, the company specializes in video laryngoscopy systems, flexible fiber optic laryngoscopes, anesthesia pharyngeal laryngoscopes, and related airway management instruments. The company produces the SMT series medical visualization laryngoscopes used in anesthesia departments, emergency care, ICU, and pediatric settings for intubation, emergency ventilation, and difficult airway management. Products feature cold light source illumination (6000 Lux), full waterproof design (IPX7 rating), photo/video capabilities, and compatibility with both reusable and disposable blades. The company holds CE0197, FDA registration, and ISO 13485 certification, with products distributed nationally and internationally across America, Europe, South Africa, and Southeast Asia.

Brain Ultimate, Inc. is a neuromodulation and neurophysiology company offering FDA-cleared transcranial magnetic stimulation (TMS) systems for depression and obsessive-compulsive disorder, as well as comprehensive neurophysiology diagnostic equipment through its EB Neuro division. The company's flagship Brain Ultimate TMS system is distinguished by proprietary deionized water cooling technology enabling true 24/7 continuous operation without overheating—a capability unique in the TMS market. The system offers four FDA-cleared treatment protocols: Standard MDD (19 min), iTBS accelerated protocol (3 min), Enhanced MDD (37 min), and OCD-targeted protocol (18 min). The device features intelligent system monitoring with automatic safety cutoffs at 42°C, precision targeting via 10-20 system caps and neuronavigation compatibility, and cloud-connected treatment management through the HIPAA-compliant Brain Ultimate Cloud platform ($150/month base). Operating in 50+ clinics nationwide, the company reports 208 peer-reviewed studies and 5,000+ study participants supporting its technology. Through EB Neuro—a sister company with 70+ years of European neurophysiology expertise—Brain Ultimate also supplies FDA-cleared EEG, EMG/EP, and critical care monitoring platforms across multiple configurations (BE Plus PRO, BE Plus LTM, Neurotravel Light, ICU EEG-SEP, NeMus Series, BE Micro), serving 50+ countries. Manufacturing is conducted in partnership with Shenzhen Yingchi Technology Co., Ltd. The company operates with no per-pulse or per-use fees and provides 24/7 technical support.

Universal Diagnostic Solutions (UDS) is an FDA-registered medical device distributor and reseller specializing in new, pre-owned, refurbished, and demo ultrasound imaging systems and complementary diagnostic medical equipment. With over 15 years of experience, UDS represents all major ultrasound manufacturers including GE, Philips, Mindray, Sonosite, Samsung, and Terason. The company provides a full-service model encompassing sales consultation, equipment customization, installation, operator training, and ongoing technical support. Product portfolio includes portable and console-based ultrasound systems, C-arm fluoroscopy X-ray equipment, vital signs monitors (NIBP, SpO2, temperature), patient examination tables (partnered with Oakworks for abdominal, musculoskeletal, vascular, and biopsy applications), and automated external defibrillators (AEDs). UDS serves diverse markets including private practices, academic medical centers, veterinary sonography, osteopathic schools, and rehabilitation clinics. The company operates a warehouse facility in Vista, California, and offers nationwide distribution with localized support through manufacturer partnerships (Mindray and Edan maintain US service locations). UDS is compliant with California State Board of Pharmacy regulations and authorized to sell Class II medical devices. The company emphasizes personalized customer engagement, rapid service turnaround, competitive pricing strategies (advertising 40% discounts on console systems), and extensive product knowledge to assist buyers in navigating the complex diagnostic imaging marketplace.

Medical Outfitters Inc. is a diagnostic imaging equipment distributor and service provider with over 20 years of industry experience. The company specializes in representing leading manufacturers including Fujifilm, Esaote, SonoSite, DMS Imaging, Planmed, Mammotome, Orthoscan, Ziehm, and KubTec. Product portfolio encompasses MRI systems (1.5T and 3T fixed systems, open MRI, extremity systems), CT scanners (16-slice to 128-slice), X-ray systems (portable and fixed digital radiography), mammography systems (2D and 3D), C-ARM and fluoroscopy systems, cone-beam CT, bone densitometry, ultrasound (portable to premium systems), biopsy guidance systems, and specimen imaging. The company also distributes AI-enhanced imaging solutions (SwiftMR for MRI optimization) and PACS/clinical visualization software. Medical Outfitters provides end-to-end services including facility planning and design consultation, equipment delivery and logistics, white-glove installation, applications training, preventive maintenance programs, emergency repair services, cryogenic support, replacement parts inventory, and interim mobile imaging solutions (fully equipped MRI, CT, and imaging trailers). Service territory covers the Eastern, Midwestern, and Western United States, Puerto Rico, the Caribbean, and Latin America. The company maintains a comprehensive warehouse and OEM-trained service technician network to minimize facility downtime.

United Imaging Healthcare develops and manufactures advanced medical imaging equipment with a mission to provide Equal Healthcare for All. The company produces a comprehensive multi-modality portfolio including CT, MRI, PET/CT, and digital X-ray systems. Key product lines include the uCT® ATLAS CT scanner (up to 640 slices), uMR® 680 1.5T MRI system with uAiFI AI capabilities, uMI® Panorama digital high-resolution PET/CT, and uDR® 380i Pro digital mobile X-ray systems. The company also manufactures the uDR® Aurora CX system and operates translational imaging, interventional X-ray, and remote scanning capabilities. United Imaging serves hospital systems, diagnostic imaging centers, precision medicine facilities, and rural healthcare providers across the United States. The company has demonstrated FDA clearance for multiple products and maintains active research partnerships with academic medical centers including UCSF and UC Davis, focusing on applications in oncology, infectious disease diagnosis, and precision healthcare. Products emphasize accessibility, clinical intelligence, and high-resolution imaging capabilities. The organization participates actively in major medical imaging conferences including RSNA, AHRA, SNMMI, and ISMRM.

SealCath, LLC is a Service-Disabled Veteran Owned Small Business (SDVOSB) founded in 2013 and headquartered in Mount Pleasant, South Carolina. The company manufactures the Cephus Catheter, an FDA-cleared double balloon colorectal catheter designed for contrast enema procedures, rectal contrast CT imaging, CT colonography (virtual colonoscopy), air enema reduction of intussusceptions, and colostomy studies. The Cephus Catheter features a unique dual balloon design that creates both internal and external sealing to achieve a leak-proof rectal seal, significantly reducing procedure time and improving imaging quality. Key benefits include enhanced patient comfort, reduced contrast leakage, minimal linen usage, and improved colonic distention. The device is particularly valued in pediatric radiology, body imaging, and interventional radiology settings for managing patients with special needs, neurogenic bowel conditions, and fecal incontinence. The product line includes pediatric and adult sizes. SealCath holds FDA clearance and is actively expanding distribution through qualified partners with prior radiology sales experience. The company now ships to Canada and is seeking distributors in both the United States and Canada. Manufacturing capabilities and regulatory quality systems support hospital and outpatient clinical facility use.

Composite Manufacturing, Inc. (CMI) is an FDA-registered manufacturer and biomedical engineering company specializing in advanced carbon fiber and composite medical device design and production. For over 40 years, CMI has engineered custom composite solutions for neurological surgery, interventional neuroradiology, orthopedic procedures, urological interventions, and general surgical practices. The company manufactures radiolucent patient positioning systems, surgical tables, and imaging-compatible equipment featuring carbon fiber composites that are up to 5x stronger than aluminum at a fraction of the weight. CMI provides end-to-end capabilities including in-house design, tooling, prototyping, and manufacturing with vertical integration ensuring superior quality control, cost efficiency, and rapid market response. Their proprietary technologies enable complex geometries and high-performance solutions for demanding medical, surgical, and imaging applications.

NeoLight, LLC manufactures specialized medical devices for neonatal intensive care, including brain monitoring, retinal imaging, phototherapy, and developmental support systems. The company's product portfolio addresses critical clinical needs in NICU environments: the nëo™ CFM with aEEG provides cerebral function monitoring to support decision-making in neurological assessment; the ICON™ retinal imaging system with patented Direct Illumination™ technology enables screening for retinopathy of prematurity and other ocular conditions; the Skylife™ Neonatal Phototherapy System delivers spectral power-optimized treatment for neonatal jaundice; and the P.A.L. (Pacifier-Activated Latch) device encourages non-nutritive sucking to promote oral feeding development in preterm and critically ill infants. NeoLight's devices are designed for use in tertiary and secondary neonatal care settings, emphasizing evidence-based clinical outcomes and user-centered design. The company positions itself as a neonatal innovation leader integrating advanced monitoring, diagnostic imaging, and therapeutic technologies to improve developmental outcomes and reduce NICU length of stay.

Invenio Imaging, Inc. develops and commercializes the NIO Laser Imaging System, a stimulated Raman histology (SRH) platform that enables rapid, label-free tissue imaging for intraoperative pathology assessment. The NIO system delivers high-quality histological images in under 3 minutes without requiring tissue staining or sectioning, allowing on-site evaluation by surgical and pathology staff. The platform features the NIO Slide sample preparation module and integrates natively with existing hospital IT infrastructure via DICOM interfaces for digital image sharing and archiving. Invenio Imaging also offers NIO Glioma Reveal, a deep learning–based image analysis algorithm for identifying cancer infiltration in glioma surgery; this product has received CE Mark approval in the European Union and is available for research use only in the United States. The company serves multiple surgical specialties including neurosurgery, interventional pulmonology, urology, ENT, breast oncology, GI endoscopy, organ transplantation, and nephrology. The technology preserves tissue viability for downstream molecular and genetic analysis, enabling pathologists to conduct additional studies on the same specimen. The NIO platform has exceeded 2,000 installed systems globally and is supported by clinical evidence from leading academic medical centers including NYU Langone Health and University of Freiburg.

Clinical Technology Inc. is a medical device and supplies distributor serving hospitals across 25 states since 1978. The company specializes in hospital-wide solutions spanning neonatal intensive care (NICU), IV therapy and enteral feeding, pharmacy compliance products, critical care and anesthesia supplies, and interventional radiology essentials. Clinical Technology functions as a wholesale medical supplier with distribution, warehousing, dedicated sales coverage, and clinician education capabilities. The company emphasizes standardization, inventory optimization, infection-prevention protocols, and regulatory compliance (USP <797>/<800> pharmacy standards). Key service areas include enteral feeding solutions, vascular access products, hazardous-drug handling and cleanroom supplies, perioperative and ICU accessories, fluoroscopy-guided procedure support, and protective apparel for interventional radiology. Clinical Technology partners with manufacturers and startups as an approved vendor with ethical partnerships and documentation support for hospital audits. The company markets itself as a compliance-first, patient-care-focused distributor with retention-based training programs and interoperable product integration. Founded in 1978, the organization has received multiple "Distributor of the Year" awards while maintaining focus on patient outcomes and staff safety. Primary markets include hospital networks requiring standardized procurement, regulatory documentation, and clinician training across multiple departments.

Slater Endoscopy, LLC is a Florida-based medical device manufacturer specializing in minimally invasive flexible endoscopic surgical instruments. The company designs and manufactures the ENSIZOR® line of flexible endoscopic scissors, available in both standard and monopolar (electrosurgical) configurations. The ENSIZOR® features patented Edge Flex™ technology, which employs twin-blade construction (one stiff blade for durability and one flexible blade for optimal cutting performance) to enhance cutting efficiency beyond conventional scissors designs. The scissors are designed for tissue dissection, resection, transection, and suturing tasks during flexible endoscopic procedures such as laparoscopy. All products are manufactured as single-use, sterile devices. The company operates a full-service facility in Miramar, Florida, that includes engineering, manufacturing, and clean-room assembly capabilities. ENSIZOR® scissors feature ultra-smooth controlled rotation for precise radial positioning and blunt-tipped outer blades to minimize tissue trauma during dissection. The company has demonstrated product performance through comparative cutting studies available on video documentation. Slater Endoscopy serves the surgical endoscopy market, particularly surgeons performing minimally invasive procedures requiring precise cutting and hemostasis control.

Johnson & Johnson is a multinational healthcare company founded in 1886 in New Brunswick, New Jersey. It specializes in pharmaceuticals, medical devices, and consumer health products. The company operates primarily through two business divisions: Innovative Medicine and MedTech. Innovative Medicine develops therapies across oncology, immunology, neuroscience, and cardiopulmonary disease areas. MedTech innovates at the intersection of biology and technology, focusing on minimally invasive and personalized treatments in cardiovascular, orthopedic, surgical, and vision care. J&J's portfolio includes surgical supplies, antiseptic sutures, diagnostic devices, and therapeutic equipment. With over 260 subsidiaries and 130,000+ employees globally, J&J is one of the largest and most diversified healthcare organizations, committed to addressing complex health challenges through rigorous science and innovation.

Rebion, Inc. commercializes Neural Performance Scanning (NPS), a proprietary technology platform that measures neurophysiologic mechanisms of the optic nerve/brain continuum through retinal scanning. The company's primary product, Blinq®, is an FDA-cleared portable point-of-care neural performance scanner designed for pediatric vision screening. Blinq directly detects micro-strabismus and amblyopia (lazy eye) by quantifying bilateral fixation and saccadic eye movements, achieving up to 100% sensitivity and over 90% specificity in clinical evaluations. The device performs a 3-second neural performance scan capable of detecting binocularity impairments associated with as little as 1-degree misalignment. Rebion's technology is supported by peer-reviewed clinical studies and research conducted at major medical institutions. The company also develops Traq™, an investigational device leveraging NPS to measure visual tracking impairments for clinical research purposes (currently not available for sale in the United States). Rebion serves diverse markets including community screeners, schools and administrators, clinical staff, parents, and caregivers. The platform enables early disease detection, intervention, and customized treatment across clinics, schools, and public health initiatives, reducing unnecessary referrals while improving diagnostic accuracy and patient outcomes.

DeepHealth is a global leader in AI-powered health informatics and radiology solutions, headquartered in Somerville, Massachusetts and operating as a subsidiary of RadNet, Inc. Founded in 2015, the company develops cloud-native platforms that integrate diagnostic imaging tools with advanced artificial intelligence to enhance clinical workflows and patient outcomes. DeepHealth OS, the company's core cloud-native operating system, unifies enterprise data and provides AI-driven insights tailored for radiologists and care teams. The platform supports detection, assessment, and monitoring across multiple imaging modalities. Key clinical AI solutions include breast cancer screening (Breast Suite with ProFound Pro and Safeguard Review), lung cancer management, prostate health, and brain health diagnostics. DeepHealth's remote scanning capability (TechLive™) enables multimodality, vendor-agnostic imaging delivery. The company serves over 300 screening sites globally and processes more than 15 million annual exams across the U.S. and Europe. Recent strategic acquisitions of Gleamer, CIMAR UK, and Alpha RT assets have expanded DeepHealth's portfolio in clinical AI, image management, and remote staffing services.

GEOTEK Medical USA LLC is a medical device manufacturer specializing in minimally invasive diagnostic and therapeutic equipment, primarily serving urology and radiology disciplines. The company manufactures biopsy needles, disposable needle guides, and transperineal needle guide systems used in image-guided procedures. Founded in 2003, GEOTEK established its US operations office in New York in 2021. The company operates a certified production facility and holds FDA 510(k) clearance for its disposable needle guide products (obtained 2017), along with CE and ISO certifications (obtained 2009). Products are designed for precision needle placement in biopsy and therapeutic interventions, supporting both diagnostic imaging-guided and interventional procedures in urology and radiology departments.

Kent Elastomer Products, Inc. (KEP) is a manufacturer based in Kent, Ohio, specializing in thermoplastic elastomer (TPE), natural rubber latex, and related products. Founded in 1960, KEP is the only remaining U.S. manufacturer of dipped natural rubber latex tubing. The company produces a comprehensive range of precision-engineered products including latex tubing, PVC tubing, TPE tubing, dip-molded parts, surgical tubing, and Free-Band® tourniquets. KEP serves medical, dental, biopharmaceutical, food and beverage, laboratory, sports, and industrial markets with custom solutions and value-added assembly services. The company emphasizes American-made production, innovation, sustainability, and maintains annual certifications for quality and performance. KEP offers high-purity TPE tubing designed specifically for biopharmaceutical applications featuring low leachables and high burst strength, alongside assembly services, prototype development, and ultrasound probe covers.

DeepTek Medical Imaging is an India-based artificial intelligence software company specializing in radiology workflow automation and diagnostic support. The company develops cloud-based AI platforms and clinical decision support tools for medical imaging. Primary products include Augmento Enterprise (FDA-cleared AI deployment platform and cloud PACS with advanced viewer for CT/MR/PET-CT imaging and comprehensive analytics), Genki (AI-powered lung health and tuberculosis screening solution with integrated RIS and VIM), and Augmento X-Ray (chest X-ray reporting automation tool with automated segregation and structured clinical report generation). The company serves radiology departments, diagnostic imaging centers, and public health organizations globally, with particular strength in TB and respiratory screening applications. DeepTek holds US FDA clearance for Augmento Enterprise and Augmento X-Ray, CE MDR Class IIb certification for chest X-ray AI, and WHO recommendation for TB screening. The platform integrates with major cloud providers (AWS, Google Cloud, Microsoft Azure) and partners with leading PACS vendors and healthcare systems across Asia, Africa, and North America. Founded by radiologists and data scientists, DeepTek emphasizes responsible AI with post-deployment surveillance capabilities.

INRAD designs and manufactures interventional medical devices for diagnostic and therapeutic procedures, with a strong focus on breast interventions and percutaneous biopsy applications. The company specializes in core needle biopsy instruments, breast tissue markers, and ultrasound-enhanced needles for image-guided procedures. Key product lines include the Trilogy breast tissue markers (available in five unique shapes for ultrasound-guided placement), the PreciseCore biopsy device (a precision core needle biopsy instrument featuring a "no-throw" mechanism to reduce specimen damage), and SampleMaster ultrasound-enhanced needles with proprietary HiLiter® ultrasound enhancement for improved visibility during percutaneous drainage and fine needle aspiration procedures. INRAD also manufactures fine needle aspiration syringe guns and related interventional accessories. The company emphasizes quality manufacturing and precision engineering to support radiologists and interventional specialists in accurate tissue sampling and marking. Products are designed for use in breast biopsy, percutaneous soft tissue biopsy, fine needle aspiration, and image-guided drainage access procedures. INRAD serves hospital radiology departments, outpatient imaging centers, and interventional practices across the United States.

Argon Medical Devices is an interventional medical device manufacturer with over 50 years of experience developing innovative solutions for interventional radiologists, cardiologists, and specialists. The company specializes in minimally invasive devices for vascular intervention, oncology, and image-guided procedures. Their product portfolio includes thrombectomy systems (CLEANER rotational and CLEANER Vac for peripheral and pulmonary emboli removal), retrievable vena cava filters (Option ELITE), drainage catheters (SKATER all-purpose and nephrostomy), biopsy instruments (BioPince Ultra full-core biopsy), and microcatheters for oncology applications (SeQure and DraKon, acquired 2024). The company serves global markets across North America, Europe, Asia, and Africa. Argon maintains manufacturing and distribution capabilities, recently expanding with a modern mixed-use facility for international operations and customer training. The company focuses on procedural efficiency, clinical efficacy, and improved patient outcomes through evidence-based device design. Products target interventional procedures including thrombectomy, vascular access, biopsy, embolization, and drainage applications. Argon demonstrates active clinical engagement through prospective multicenter studies (CLEAN-PE study for pulmonary embolism treatment) and continuous portfolio expansion in liver management and oncology segments.

PaxeraHealth is a Boston-based enterprise medical imaging software company specializing in AI-driven imaging platforms and solutions. The company develops advanced Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and vendor-neutral archive (VNA) platforms designed for healthcare providers globally. PaxeraHealth's core portfolio includes PaxeraUltimaAI—an AI-assisted enterprise imaging platform with native diagnostic algorithms to enhance workflow efficiency and reporting speed; ARK—a no-code imaging algorithm platform enabling users to develop multimodal AI algorithms without coding expertise; and VNAi—a data warehouse imaging platform providing secure, vendor-neutral control of imaging data with advanced lifecycle management. The company serves over 1,500 healthcare customers across 45 countries, managing 220+ million imaging studies annually. PaxeraHealth's solutions emphasize workflow automation, diagnostic accuracy improvement, clinical decision support, and seamless interoperability with existing EMR and PACS systems. The company employs approximately 106 people from 12 countries and maintains regional offices and a global distributor network to support healthcare systems of all sizes.

XPress BCD LLC manufactures the XPress BCD™ (Breast Compression Device), a reusable medical device designed for use with stereotactic biopsy platforms. The device applies temporary focal mechanical compression to stereotactic breast biopsy sites to achieve hemostasis and reduce post-biopsy hematoma formation. The XPress BCD is a thermoplastic, modular unit available in three geometric configurations, each compatible with standard biopsy paddle systems. Clinical data demonstrates a 70% reduction in hematoma incidence (7.5% vs. 25.4-43% with manual compression) and 50% reduction in hematoma size. The device is reusable, requires only low-cost disposable latex-free covers, and provides operational efficiencies including approximately 11 minutes of labor savings per biopsy procedure. It eliminates ergonomic strain on clinical staff during post-biopsy compression and maintains accurate collinearity of bleeding sites. Patient satisfaction ratings exceed 97% (good-to-excellent). The device is FDA-cleared and intended for breast biopsy applications in interventional radiology and surgical settings.

Marco is a leading supplier of ophthalmic diagnostic and refraction equipment serving optometry and ophthalmology practices across North America. The company manufactures and distributes a comprehensive portfolio of vision-testing and examination technologies, including automated refraction systems, wavefront aberrometers, slit lamps, tonometers, autorefractors, lensmeters, examination chairs, imaging systems (retinal and ocular), acuity chart projectors, and instrument stands. Key product lines include the TRS (digital refractors: TRS-6100, TS-610 with FARS), OPD-Scan III wavefront aberrometer, EPIC refraction workstations, Ultra M5 slit lamps, iON retinal imaging systems, AL-Scan optical biometers, and Encore automatic examination chairs. Marco merged with Lombart Healthcare in June 2024 to form Marco Lombart under the Advancing Eyecare umbrella, expanding its product offering to include additional diagnostic devices. The company emphasizes integrated workflow solutions, ergonomic design, staff efficiency, and patient experience. Marco maintains direct distribution and support operations, with manufacturing quality backed by one-year warranties on materials and workmanship. The product portfolio is widely adopted by independent and group optometry practices, eye care clinics, and refractive/cataract surgery centers.

Phelcom Technologies is a medical device manufacturer specializing in portable ophthalmic imaging solutions. The company designs and produces the Eyer and Eyer2 portable fundus cameras—high-quality, portable retinal imaging devices capable of capturing fundus images with 55 degrees of visual field and anterior segment photography. Eyer2 represents their latest iteration, marketed as the world's first high-quality portable fundus camera. The company operates a cloud-based image management platform, EyerCloud, enabling automatic and secure exam storage and accessibility. Phelcom's devices are positioned for use in diverse clinical settings including private optometry practices, ophthalmology clinics, pediatric care, and remote/resource-limited environments. The Eyer devices have been featured in peer-reviewed research and are approved by regulatory bodies including ANVISA (Brazilian health authority, Class II medical device) and cleared for use in multiple countries. The company provides training and support services for end users and maintains a US headquarters in Cambridge, Massachusetts. Customer testimonials emphasize ease of use, image quality, portability, and utility for patient education and anterior segment documentation. Phelcom has received investment backing from established healthcare and life science funds, signaling credibility in the medical device space.

CenterPoint Systems LLC manufactures innovative medical devices and products serving the cardiovascular, respiratory, gastrointestinal, and critical care markets. Based in West Valley City, Utah, the company develops specialized equipment for acute and critical care settings, with a focus on supporting clinical outcomes in high-acuity patient populations. CenterPoint serves healthcare facilities through direct sales and customer support channels.

B'ORZE Inc., America is an international medical device manufacturer specializing in digital colposcopes and fetal monitoring systems. Based in Boise, Idaho, the company has established a worldwide reputation for producing high-quality gynecological and obstetric equipment. B'ORZE leverages digital engineering technology to deliver innovative solutions with flexibility and cost-effectiveness. The company maintains a commitment to uncompromising quality and customer satisfaction, supported by decades of industry experience in meeting diverse clinical demands. Their product portfolio includes advanced digital video colposcopes and cardiotocography/fetal monitors designed for gynecological and maternal health applications.

MIM Software Inc., a GE HealthCare company founded in 2003, is a vendor-neutral medical imaging software provider serving over 3,300 healthcare organizations globally, including 90% of the world's top 50 hospitals. The company specializes in imaging analysis and clinical workflow software for radiation oncology, nuclear medicine, cardiology, theranostics, neurology, and urology. Key offerings include MIM Encore™ for digital imaging and workflow solutions, AI Auto-Contouring tools for treatment planning, MIM Symphony Dx™ for prostate MRI visualization and analysis, MIM LesionID™ Pro for automated tumor burden analysis, and MIM ComboTherapy™ GYN HDR/EBRT for combined gynecologic cancer treatment planning. Solutions emphasize standardization, automation, and AI-driven enhancements to improve clinical efficiency, patient safety, and precision care delivery across oncology, diagnostic imaging, and specialty medicine applications.

Mirada Medical is a UK-based medical imaging software company founded in 2000, with deep roots in Oxford University research (originating from 1998). Headquartered in Oxford, the company specializes in AI-driven, vendor-neutral software solutions designed to accelerate cancer care through precision imaging. The company's portfolio targets three primary clinical domains: radiation oncology, diagnostic imaging, and interventional radiology. Key products include Mirada RTx, which automates radiation therapy planning workflows and enhances treatment planning confidence, and Mirada XD, an advanced image registration and visualization platform for enterprise diagnostic imaging. Mirada's solutions incorporate deep learning and AI-based quantification tools to support clinician productivity, multi-timepoint follow-up analysis, and automated reporting (particularly for PET/CT and PET/MR imaging). The company maintains strong partnerships with major medical device manufacturers including Canon and Boston Scientific, and collaborates with clinical facilities on research-driven innovation to improve patient outcomes and address imaging-related clinical challenges.

INFINITT Healthcare is a global enterprise imaging software and services company headquartered in Seoul, South Korea, with operations spanning 56 countries. Founded in 2002, INFINITT specializes in Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and vendor-neutral imaging solutions for healthcare institutions. The company has deployed over 6,500 installations across hospitals, imaging centers, and specialty practices. INFINITT's core product portfolio includes INFINITT PACS 7.0, a web-based diagnostic viewer with AI-enabled reading workflows; INFINITT Cardiology Suite for cardiovascular and nuclear medicine imaging; INFINITT Digital Pathology Solution (IDPS) for quantitative histopathology analysis and remote consultation; INFINITT RT PACS for radiotherapy treatment planning and management; and Versity Dental platform for dental imaging in academic settings. The company emphasizes interoperability, cloud-based and on-premise deployment options, multi-disciplinary team collaboration tools (INFINITT MDT), and integrated electronic health record connectivity. INFINITT combines in-house R&D with customer-driven customization, lifecycle support, and IT security compliance to address radiology, cardiology, pathology, dental, and veterinary imaging workflows.

Loocid LLC is a Miami-based medical device innovator specializing in computer-assisted surgical solutions for dental implant and bone surgery procedures. The company designs and manufactures specialized drill kits with thermal control technology (Loocid BCP™ system) that minimize bone cell trauma and preserve healthy bone during osteotomy preparation. Their product line includes custom and universal implant drill kits engineered to reduce thermal trauma during bone drilling, support osseointegration, and accelerate patient healing. Loocid combines mechanical drilling innovations with 3D imaging technology and AI-driven digital workflows to enable minimally traumatic surgical techniques. The company targets dental surgeons, oral and maxillofacial surgeons, and orthopedic professionals seeking clinically-proven tools that improve patient outcomes and reduce post-operative complications.

Twins & Martin is a leading global distributor of medical devices specializing in endovascular therapy solutions. The company provides a comprehensive portfolio of products spanning peripheral vascular, cardiovascular, venous, and interventional radiology applications, serving healthcare facilities across more than 30 countries for over 30 years. BMC Medical Manufacturing operates as part of Twins & Martin's distribution network, focusing on high-quality medical technology solutions including guide wires, balloon catheters, vascular stents, and catheterization lab equipment. The company emphasizes innovation, quality assurance, regulatory compliance (FCPA, UK Bribery Act), and customer service to support better patient outcomes in endovascular interventional procedures.

Zumax Medical Co., Ltd. is a leading Chinese manufacturer of high-precision medical and optical instruments, established in 2005 and recognized as a National High-tech Enterprise. Based in Suzhou, Jiangsu, with ~290 employees and ISO 13485 certification, the company specializes in optical diagnostic and surgical equipment serving dental, ophthalmic, ENT, and general surgical markets. Core product categories include dental surgical microscopes (OMS series), ophthalmic diagnostic instruments (slit lamps, retinoscopes, ophthalmoscopes), ENT endoscopy systems, surgical loupes (prismatic and TTL binocular designs), LED headlights, and accessory instruments. Zumax emphasizes precision engineering and cost-effectiveness, with active participation in international trade shows and strong R&D capabilities. The company targets healthcare professionals across dental, ophthalmic, ENT, and surgical specialties, with particular market focus on international regions including Europe and the UK.